GlassScriptPhysician profile
Sandra R Raynor
NPI 1831158526
$8,818.86
in general payments reported to CMS, 2019-2025
38 companies · $895 in 2025
The $895 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $605 · 2020: $3,312 · 2021: $2,522 · 2022: $251 · 2023: $584 · 2024: $650 · 2025: $895.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,127.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Crossroads Orthopedics, LLC | $4,417.79 | 2020-2024 | |
| Stryker Corporation | $1,106.16 | 2019-2025 | Actishield, Flexband, Ct Thrombectomy System Kit |
| In2bones USA, LLC | $1,000.00 | 2020 | |
| Depuy Synthes Sales INC. | $382.85 | 2019-2025 | Motoband, Fibergraft Aeridyan Matrix, N/A |
| Medtronic, INC. | $205.23 | 2022-2025 | Intellis Adaptivestim |
| Abbott Laboratories | $162.51 | 2023-2025 | Diamondback Peripheral, Proclaim |
| Organogenesis INC. | $148.45 | 2022-2024 | |
| Averitas Pharma INC. | $139.89 | 2023-2025 | Qutenza |
| Zimmer Biomet Holdings, INC. | $125.43 | 2019-2020 | |
| Paragon 28, INC. | $109.14 | 2019 | |
| Orthofix Medical, INC. | $106.15 | 2023-2025 | Physio-Stim |
| Smith+Nephew, INC. | $104.37 | 2019-2024 | Grafix Pl |
| Kerecis Limited | $99.71 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Vertex Pharmaceuticals Incorporated | $97.02 | 2024-2025 | |
| Nabriva Therapeutics, Plc | $68.49 | 2021-2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $54.90 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $40.09 | 2019 | |
| Nevro Corp. | $34.36 | 2024 | Senza |
| Paratek Pharmaceuticals, INC. | $33.86 | 2023 | Nuzyra |
| Boston Scientific Corporation | $31.34 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Kci USA, INC. | $30.35 | 2019-2020 | |
| Tactile Systems Technology INC | $28.79 | 2019-2025 | Flexitouch Plus, Nimbl |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $27.74 | 2020-2021 | |
| Misonix INC | $24.44 | 2020 | |
| Cardiovascular Systems INC. | $22.37 | 2019 | |
| Bioventus LLC | $21.83 | 2019 | |
| Surgenex LLC | $19.32 | 2025 | Ardeograft, Surgraft, Surmatrix |
| Curonix LLC | $19.19 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Djo, LLC | $18.90 | 2025 | Cmf |
| Pacira Pharmaceuticals Incorporated | $18.00 | 2019 | |
| Polynovo North America LLC | $17.59 | 2023 | |
| Treace Medical Concepts, INC. | $16.67 | 2022 | |
| Alfasigma USA, INC. | $15.84 | 2021 | |
| Medtronic Vascular, INC. | $14.87 | 2019 | |
| Arteriocyte Medical Systems, INC. | $14.16 | 2019 | |
| Urgo Medical North America, LLC | $13.85 | 2023 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Heron Therapeutics, INC. | $13.83 | 2021 | |
| Horizon Therapeutics Plc | $13.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Raynor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.